ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Feb 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
January 2026
Latest News
Mirion announces appointments
Mirion Technologies has announced three senior leadership appointments designed to support its global nuclear and medical businesses while advancing a company-wide digital and AI strategy. The leadership changes come as Mirion seeks to advance innovation and maintain strong performance in nuclear energy, radiation safety, and medical applications.
D. C. Kocher
Nuclear Technology | Volume 48 | Number 2 | April 1980 | Pages 171-179
Technical Note | Radioisotope | doi.org/10.13182/NT80-A32463
Articles are hosted by Taylor and Francis Online.
Dose reduction factors from indoor residence during routine releases of radionuclides to the atmosphere have been studied using models that are suitable for application to arbitrary source terms. Dose reduction factors for internal exposure to inhaled radionuclides account for air ventilation and deposition on inside building surfaces. Estimated internal dose reduction factors are 0.2 to 0.8 for particulates and 0.07 to 0.4 for radioiodine. Dose reduction factors for external photon exposure from airborne and surface-deposited sources are based on the point-kernel integration method. Values for source terms from a fuel reprocessing plant and a hypothetical reactor accident are within a factor of 2 of the value 0.5 adopted by the U.S. Nuclear Regulatory Commission (NRC) for population dose assessments. For the release at Three Mile Island nuclear station, however, the external dose reduction factor may be an order of magnitude less than the value adopted by the NRC.